Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, GRI Bio Inc increased its cash reserves by 19,988.89%, or 1.80m. Cash Flow from Financing totalled 10.80m or -- of revenues. In addition the company used 8.99m for operations while cash used for investing totalled 8.00k.
Cash flow per share | -38.15 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 5.88 |
---|---|
Tangible book value per share | 5.88 |
More ▼
Balance sheet in USDView more
Current ratio | 3.11 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼